Jose L. Blanco-Arevalo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naïve Adults With HIV.

Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naïve Adults With HIV.

Journal: Open forum infectious diseases

Published: January 23, 2026

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 10, 2025

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 10, 2025

Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial.

Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 12, 2024

Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.

Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.

Journal: AIDS reviews

Published: January 01, 2024

mRNA Detection in Anal Cytology: A Feasible Approach for Anal Cancer Screening in Men Who Have Sex with Men Living With HIV.

mRNA Detection in Anal Cytology: A Feasible Approach for Anal Cancer Screening in Men Who Have Sex with Men Living With HIV.

Journal: Diagnostics (Basel, Switzerland)

Published: June 29, 2019

Sexually transmitted diseases of the anus and rectum: Causal agents, coinfections, HIV infection and high-risk sexual behaviour.

Sexually transmitted diseases of the anus and rectum: Causal agents, coinfections, HIV infection and high-risk sexual behaviour.

Journal: Medicina clinica

Published: November 25, 2017

Darunavir as initial therapy for human immunodeficiency virus infection and as a strategy for switching regimen not motivated by virological failure

Darunavir as initial therapy for human immunodeficiency virus infection and as a strategy for switching regimen not motivated by virological failure

Journal: Enfermedades infecciosas y microbiologia clinica

Published: January 14, 2017

Sexually Transmitted Infections: Experience in a Multidisciplinary Clinic in a Tertiary Hospital (2010-2013).

Sexually Transmitted Infections: Experience in a Multidisciplinary Clinic in a Tertiary Hospital (2010-2013).

Journal: Actas dermo-sifiliograficas

Published: June 15, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026